An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W, Wakelee, Heather A, Merritt, Robert E, Shrager, Joseph B, Loo, Billy W, Alizadeh, Ash A, Diehn, Maximilian·2014·Nature Medicine

DOI 10.1038/nm.3519

Cited by (1,002)

Items 801–900 of 1,002

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
Chin Fung Kelvin Kan, Graham D. Unis, Luke Z. Li, Susan Gunn, Li Li, H. Peter Soyer, Mitchell S. Stark · 2021 · Frontiers in Oncology
Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Catherine Diefenbach, Brad S. Kahl, Andrew McMillan, Javier Briones, Lalita Banerjee, Raúl Córdoba, Fiona M. Miall, John M. Burke, Jamie H. Hirata, Yanwen Jiang et al. · 2021 · The Lancet Haematology
Imaging immunity in patients with cancer using positron emission tomography
Fiona Hegi‐Johnson, Stacey E. Rudd, Rodney J. Hicks, Dirk De Ruysscher, Joseph A. Trapani, Thomas John, Paul S. Donnelly, Benjamin J. Blyth, Gerard G. Hanna, Sarah Everitt et al. · 2022 · npj Precision Oncology
Circulating DNA in EGFR-mutated lung cancer
Aditi Puri Singh, Shenduo Li, Haiying Cheng · 2017 · Annals of Translational Medicine
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal
Christine M. Bestvina, Marina Chiara Garassino, Joel W. Neal, Heather A. Wakelee, Maximilian Diehn, Everett E. Vokes · 2023 · Journal of Clinical Oncology
Liquid-based biomarkers in breast cancer: looking beyond the blood
You Shuai, Zhonghua Ma, Jie Ju, Tong Wei, Songlin Gao, Yi‐Kun Kang, Zixuan Yang, Xue Wang, Jian Yue, Peng Yuan · 2023 · Journal of Translational Medicine
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients’ Care
Monica Sorbini, Tullia Carradori, Gabriele Togliatto, Tiziana Vaisitti, Silvia Deaglio · 2024 · Biomolecules
Multi-cancer early detection tests for general population screening: a systematic literature review
Ros Wade, Sarah J Nevitt, Yiwen Liu, Melissa Harden, Claire Khouja, Gary Raine, Rachel C. Churchill, Sofia Dias · 2024 · Health Technology Assessment
Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease
Zachary David Nagel, Bevin P. Engelward, David J. Brenner, Thomas J. Begley, Robert William Sobol, Jason H. Bielas, Peter J. Stambrook, Qingyi Wei, Jennifer J. Hu, Mary Beth Terry et al. · 2017 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions
Lincoln D. Nadauld, James M. Ford, Daryl E. Pritchard, Thomas David Brown · 2018 · Health Affairs
Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
Vanathi Perumal, Tammy Corica, Arun Dharmarajan, Zhonghua Sun, Satvinder Singh Dhaliwal, Crispin R. Dass, Joshua Dass · 2019 · Cancers
Technical progress in circulating tumor DNA analysis using next generation sequencing
Yunfei Bai, Zexin Wang, Zhiyu Liu, Geyu Liang, Wanjun Gu, Qinyu Ge · 2019 · Molecular and Cellular Probes
Impact of Reducing DNA Input on Next-Generation Sequencing Library Complexity and Variant Detection
Samantha N. McNulty, Patrick R. Mann, Joshua A. Robinson, Eric James Duncavage, John D. Pfeifer · 2020 · Journal of Molecular Diagnostics
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
Lee Steven Schwartzberg, Hidehito Horinouchi, David Lok Hang Chan, Sara Chernilo, Michaela L. Tsai, Dolores Isla, Carles Escriu, John P. Bennett, Kim Michelle Clark-Langone, Christer Svedman et al. · 2020 · npj Precision Oncology
Multimodal Analysis of ctDNA Methylation and Fragmentomic Profiles Enhances Detection of Nonmetastatic Colorectal Cancer
Huu Thinh Nguyen, Le Anh Khoa Huynh, Trieu Vu Nguyen, Duc Huy Tran, Thuy Thi Thu Tran, Nguyen Duy Khang Le, Ngoc An Trinh Le, Truong-Vinh Ngoc Pham, Minh-Triet Le, Thi Mong Quynh Pham et al. · 2022 · Future Oncology
Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
Zhoufeng Wang, Kehui Xie, Guonian Zhu, Chengcheng Ma, Cheng Cheng, Yangqian Li, Xue Xiao, Chengpin Li, Jun Tang, Hui Wang et al. · 2023 · Respiratory Research
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
Elisa Bertoli, Elisa De Carlo, Debora Basile, Diego Zara, Brigida Stanzione, Mónica Schiappacassi, Alessandro Del Conte, Michele Spina, Alessandra Bearz · 2023 · International Journal of Molecular Sciences
Precision medicine for advanced prostate cancer
Stephanie Anne Mullane, Eliezer M. Van Allen · 2016 · Current Opinion in Urology
Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
Yuping Li, Hanyan Xu, Shanshan Su, Junru Ye, Junjie Chen, Xuru Jin, Quan D. Lin, Dongqing Zhang, Caier Ye, Chengshui Chen · 2017 · PLoS ONE
Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology
Soo‐Ryum Yang, Kelly L. Mooney, Paolo Libiran, Carol D. Jones, Rohan Prakash Joshi, Hubert D. Lau, Henning Stehr, Gerald J. Berry, James L. Zehnder, Steven Long et al. · 2019 · Cancer Cytopathology
Principles of digital sequencing using unique molecular identifiers
Daniel Andersson, Firaol Tamiru Kebede, Mandy Escobar, Tobias Österlund, Anders Ståhlberg · 2024 · Molecular Aspects of Medicine
The possibility of clinical sequencing in the management of cancer
Tadayuki Kou, Masashi Kanai, Shigemi Matsumoto, Yasushi Okuno, Manabu Muto · 2016 · Japanese Journal of Clinical Oncology
Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer
Zhiyuan Fan, Wentao Liu, Chao Yan, Zhenglun Zhu, Wei Lin Xu, Jianfang Li, Liping Su, Chen Li, Zhenggang Zhu, Bingya Liu et al. · 2016 · Tumor Biology
ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
Paul M Hofman · 2017 · Cancers
Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC
Tao Jiang, Xuefei Li, Jianfei Wang, Chunxia Su, Wenbo Han, Chao Zhao, Fengying Wu, Guanghui Gao, Wei Li, Xiaoxia Chen et al. · 2017 · Theranostics
The Utility of Liquid Biopsy in Central Nervous System Malignancies
Kathryn Sara Nevel, Jessica A. Wilcox, Lindsay Robell, Yoshie Umemura · 2018 · Current Oncology Reports
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
Jun Lü, Baohui Han · 2018 · Technology in Cancer Research & Treatment
Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers
Paul Loren Swiecicki, Julia R. Brennan, Michelle Lynn Mierzwa, Matthew E. Spector, John Chad Brenner · 2018 · The Laryngoscope
Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma
Fatemeh Khatami, Bagher A. Larijani, Ramin Heshmat, Shirzad Nasiri, Mohammad Haddadi Aghdam, Ladan Teimoori‐Toolabi, Seyed Mohammad Tavangar · 2020 · Journal of Cellular Physiology
Multiplexing Liquid Biopsy with Surface‐Enhanced Raman Scattering Spectroscopy
Sara Abalde‐Cela, Lei Wu, Alexandra Teixeira, Kevin Oliveira, Lorena Diéguez · 2021 · Advanced Optical Materials
A DNA methylation-based liquid biopsy for triple-negative breast cancer
Katrina Cristall, François‐Clément Bidard, Jean‐Yves Pierga, Michael J. Rauh, Tatiana G. Popova, Clara Sebbag, Olivier J Lantz, Marc‐Henri Stern, Christopher R. Mueller · 2021 · npj Precision Oncology
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer
Jessica A. Hellyer, Maya N. White, Rebecca M. Gardner, Kristen May Cunanan, Sukhmani Kaur Padda, Millie Snigdha Das, Kavitha J. Ramchandran, Joel W. Neal, Heather A. Wakelee · 2021 · Clinical Lung Cancer
Liquid biopsy in hematological malignancies: current and future applications
Donatella Talotta, Mohammad Almasri, Chiara Cosentino, Gianluca Gaïdano, Riccardo Moia · 2023 · Frontiers in Oncology
Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms
Seunghyun Jeon, Hyungjae Lee, Kieun Bae, Kyong‐Ah Yoon, Eun Sook Lee, Youngnam Cho · 2016 · Theranostics
Label-free and high-sensitive detection of Kirsten rat sarcoma viral oncogene homolog and epidermal growth factor receptor mutation using Kelvin probe force microscopy
Kuewhan Jang, Jaeyeong Choi, Chanho Park, Sungsoo Na · 2016 · Biosensors and Bioelectronics
Dual toeholds regulated CRISPR-Cas12a sensing platform for ApoE single nucleotide polymorphisms genotyping
Yuedong Zhu, Yanan Lin, Bin Gong, Yan Zhang, Gaoxing Su, Yanyan Yu · 2024 · Biosensors and Bioelectronics
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Christopher Schroeder, Sergios Gatidis, Olga Kelemen, Leon Schütz, Irina Bonzheim, Francesc Muyas, Peter Martus, Jakob Admard, Sorin Armeanu–Ebinger, Brigitte Gückel et al. · 2024 · Nature Communications
Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis
William Yang, Romario Nguyen, Fatema Safri, Muhammad J. A. Shiddiky, Majid Ebrahimi Warkiani, Jacob George, Liang Qiao · 2025 · Current Oncology Reports
Facile single-stranded DNA sequencing of human plasma DNA via thermostable group II intron reverse transcriptase template switching
Douglas C. Wu, Alan M. Lambowitz · 2017 · Scientific Reports
Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
Helei Hou, Xiaonan Yang, Jinping Zhang, Zhe Zhang, Xiaomei Xu, Xiaoping Zhang, Chuantao Zhang, Dong Liu, Wei‐Hua Yan, Hongmei Zhu et al. · 2017 · Scientific Reports
Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy
Laura Keller, Nicolas Marie Guibert, Anne Casanova, Stéphanie Brayer, Magali Farella, Myriam Delaunay, Julia Gilhodes, Elodie Martin, G Balagué, Gilles Favre et al. · 2018 · Acta Dermato Venereologica
Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management
Pietro Fici · 2018 · Methods in molecular biology
Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors
Eiji Iwama, Kazuko Sakai, Noriko Hidaka, Koji Inoue, Akiko Fujii, Noriaki Nakagaki, Keiichi Ota, Ryo Toyozawa, Koichi Azuma, Keita Nakatomi et al. · 2019 · Cancer
CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
Seung Hwan Lee, Young‐Ho Park, Yeung Bae Jin, Sun‐Uk Kim, Junho K. Hur · 2019 · Trends in Molecular Medicine
Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer
Xiaoju Max Ma, Johanna C. Bendell, Herbert I. Hurwitz, Christine Ju, John J. Lee, Alex Lovejoy, Christoph Mancao, Alan Nicholas, Richard Price, Nicolas Sommer et al. · 2020 · Clinical Cancer Research
Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors
Justin A. Chen, Weijie Ma, Jianda D. Yuan, Tianhong Li · 2020 · Cancer treatment and research
Association between circulating tumor DNA burden and disease burden in patients with ALK‐positive lung cancer
Eric W. Zhang, Ibiayi Dagogo‐Jack, Anderson H. Kuo, Marguerite M. Rooney, Alice Tsang Shaw, Subba Rao Digumarthy · 2020 · Cancer
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, Brendan Paul Hodkinson, Gabriela Forestieri, Ferdinando Bonfiglio, Adalgisa Condoluci, Wei Wu, Maria Cristina Pirosa, Martin Faderl et al. · 2021 · Blood Advances
ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors
Wei Nie, Zhijie Wang, Kai Zhang, Bing Li, Yiran Cai, Fengcai Wen, Ding Zhang, Yuezong Bai, Xueyan Zhang, Shuyuan Wang et al. · 2022 · BMC Medicine
Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
Sadia Hassan, Adeeb Shehzad, Shahid Ali Khan, Waheed Miran, Salman Khan, Young Sup Lee · 2022 · Biomedicines
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Kirsty Ross, Emma Pailler, Vincent Faugeroux, Mélissa Taylor, Marianne Oulhen, Nathalie Auger, David Planchard, Jean‐Charles Soria, Colin R. Lindsay, Benjamin Besse et al. · 2015 · Expert Review of Molecular Diagnostics
Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma
Shan Dan, Yuan Yuan, Yaoshen Wang, Chao Chen, Changxin Gao, Song Yu, Yan Liu, Wei Song, Asan, Hongmei Zhu et al. · 2016 · PLoS ONE
Challenges and recommendations for epigenomics in precision health
Ava C. Carter, Howard Y. Chang, George McDonald Church, Ashley Dombkowski, Joseph R. Ecker, Elad Gil, Paul G. Giresi, Henry T. Greely, William James Greenleaf, Nir Hacohen et al. · 2017 · Nature Biotechnology
Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment
Wei Fang, Charles M. Strom, Jordan C. Cheng, Chien‐Chung Lin, Ching-Yun Hsu, Guy W. Soo Hoo, David Chia, Yong Kim, Feng Li, David A. Elashoff et al. · 2018 · Journal of Molecular Diagnostics
Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics
Xiaoqing Peng, Hong‐Dong Li, Fang‐Xiang Wu, Jianxin Wang · 2020 · Briefings in Bioinformatics
Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation
Maria Farooq, James Gordon Herman · 2020 · Cancer Epidemiology Biomarkers & Prevention
Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients
Qinfang Deng, Boxiong Xie, Leilei Wu, Xianxiu Ji, Chao Li, Feng Li, Qiyu Fang, Yuchen Bao, Jialu Li, Shengnan Jin et al. · 2018 · Heliyon
Liquid biopsy: creating opportunities in brain space
Trivedi, Rakesh, Bhat, Krishna P. · 2023 · British Journal of Cancer
Genomic profiling in GIST: Implications in clinical outcome and future challenges
Germán Calderillo-Ruiz, Eloy-Andrés Pérez-Yépez, M. García-Gámez, Oliver Millán-Catalán, Consuelo Díaz-Romero, Paul Ugalde‐Silva, Rodrigo Salas-Benavides, Carlos Pérez‐Plasencia, Berenice Carbajal-López · 2024 · Neoplasia
Genomic alterations in pancreatic cancer and their relevance to therapy
Erina Takai, Shinichi Yachida · 2015 · World Journal of Gastrointestinal Oncology
Advances in Circulating Tumor DNA Analysis
Samantha O. Perakis, Martina Auer, Jelena Belic, Ellen Heitzer · 2017 · Advances in clinical chemistry
Closed-Tube PCR with Nested Serial Invasion Probe Visualization Using Gold Nanoparticles
Jianping Wang, Bingjie Zou, Yinjiao Ma, Xueping Ma, Nan Sheng, Jianzhong Rui, Yang Shao, Guohua Zhou · 2017 · Clinical Chemistry
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid
Meenakshi Mehrotra, Rajesh R. Singh, Wei Chen, Richard S.P. Huang, Alaa A. Almohammedsalim, Bedia A. Barkoh, Crystal M. Simien, Marcos Hernandez, Carmen Behrens, Keyur Pravinchandra Patel et al. · 2017 · Journal of Molecular Diagnostics
Cell-free DNA as a post-treatment surveillance strategy: current status
Justin Burgener, Ariana Rostami, Daniel Diniz De Carvalho, Scott Victor Bratman · 2017 · Seminars in Oncology
Genomic Testing in Lung Cancer: Past, Present, and Future
Céline Mascaux, Ming‐Sound Tsao, Fred R. Hirsch · 2018 · Journal of the National Comprehensive Cancer Network
CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy
Rachel L. Mintz, Madeleine A. Gao, Kahmun Lo, Yeh‐Hsing Lao, Mingqiang Li, Kam W. Leong · 2018 · Advanced Biosystems
The role of circulating free DNA in the management of NSCLC
Riziero Esposito Abate, Raffaella Pasquale, Francesca Fenizia, Anna Maria Rachiglio, Cristin Roma, Francesca Bergantino, Laura Forgione, Matilde Lambiase, Alessandra Sacco, Maria Carmela Piccirillo et al. · 2018 · Expert Review of Anticancer Therapy
Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma
Yu Chun Xiong, Chengrong Xie, Sheng Zhang, Chen Jin, Zhenyu Yin · 2019 · Cancer Management and Research
Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling
Florian Scherer · 2019 · Recent results in cancer research/Recent Results in Cancer Research
Fluorescence Signal Amplification Strategies Based on DNA Nanotechnology for miRNA Detection
Tao Li, Ruilin Duan, Zhijuan Duan, Fujian Huang, Fan Xia · 2019 · Chemical Research in Chinese Universities
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients
Anne Tranberg Madsen, Anne Winther‐Larsen, Tine McCulloch, Peter Meldgaard, Boe Sandahl Sørensen · 2020 · Cancers
Advances in the assessment of minimal residual disease in mantle cell lymphoma
Da-Young Jung, Preetesh Jain, Yixin Yao, Michael L. Wang · 2020 · Journal of Hematology & Oncology
Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples
Josiah T. Wagner, Hyun Ji Kim, Katie Johnson-Camacho, Taylor Kelley, Laura F. Newell, Paul T. Spellman, Thuy T. M. Ngo · 2020 · Scientific Reports
Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potential
Lennart Raman, Malaïka Van Der Linden, Ciel De Vriendt, Bliede Van den Broeck, Kristoff Muylle, Dries Deeren, Franceska Dedeurwaerdere, Sofie Verbeke, Amélie Dendooven, Katrien C. De Grove et al. · 2020 · Haematologica
Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer
Jhanelle E. Gray, Jeffrey C. Thompson, Erica L. Carpenter, Ehab Elkhouly, Charu Aggarwal · 2021 · The Oncologist
Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content
Devika Ganesamoorthy, Alan J. Robertson, Wenhan Chen, Michael B. Hall, Minh Duc Cao, Kaltin Ferguson, Sunil R. Lakhani, Kátia Nones, Peter T. Simpson, Lachlan Coin · 2022 · BMC Cancer
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer
Alisha Heather Bent, Shreya A. Raghavan, Arvind N. Dasari, Scott Kopetz · 2022 · Clinical Colorectal Cancer
Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns
Jörg Tost · 2016 · Advances in experimental medicine and biology
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma
Zheng Wang, Gang Cheng, Xiaohong Han, Xinlin Mu, Yuhui Zhang, Di Cui, Chang Liu, Li Zhang, Zaiwen Fan, Lingyun Ma et al. · 2016 · Journal of Molecular Diagnostics
Screening for early stage lung cancer and its correlation with lung nodule detection
Fangfei Qian, Wenjia Yang, Qunhui Chen, Xueyan Zhang, Baohui Han · 2018 · Journal of Thoracic Disease
Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma
Fangtian Wu, Lu Luo, Wei Xu, Jianyong Li · 2018 · Annals of Hematology
Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma.
Gaixia He, Yanhui Chen, Chengpei Zhu, Jinxue Zhou, Xingwang Xie, Ran Fei, Lai Wei, Haitao Zhao, Hongsong Chen, Henghui Zhang · 2019 · Europe PMC (PubMed Central)
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection
Song Yi Bae, Kaylee Judith Kamalanathan, Catalina Galeano‐Garces, Badrinath R. Konety, Emmanuel S. Antonarakis, Jayant Parthasarathy, Jiarong Hong, Justin M. Drake · 2024 · Endocrinology
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
Chiara Reina, Berina Šabanović, Chiara Lazzari, Vanesa Gregorc, Christopher Heeschen · 2024 · Translational research
Feasibility of Cell-Free Circulating Tumor DNA Testing for Lung Cancer
Mariacarmela Santarpía, Niki Karachaliou, María González‐Cao, Giuseppe Altavilla, Elisa Giovannetti, Rafael Rosell · 2016 · Biomarkers in Medicine
Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients
Cristina Aguado, Ana A. Giménez-Capitán, Niki Karachaliou, Ana Pérez-Rosado, Santiago Viteri, Daniela Morales-Espinosa, Rafael Rosell · 2016 · Translational Lung Cancer Research
Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies
Ioannis Ladas, Mariana Fitarelli-Kiehl, Chen Song, Viktor A. Adalsteinsson, Heather Anne Parsons, NU Lin, Nikhil Wagle, Gerassimos Mike Makrigiorgos · 2017 · Clinical Chemistry
Technologies for analysis of circulating tumour DNA: Progress and promise
Zhen Zou, Peng Qi, Zhihe Qing, Jing Zheng, Sheng Yang, Wei‐Ju Chen, Ronghua Yang · 2017 · TrAC Trends in Analytical Chemistry
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy
Kerstin Zwirner, Franz J. Hilke, German M. Demidov, Stephan Ossowski, Cihan Gani, Olaf Rieß, Daniel Zips, Stefan Welz, Christopher Schroeder · 2018 · Radiotherapy and Oncology
Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer
Kezhong Chen, Guannan Kang, Heng Zhao, Kai Zhang, Jian Zhang, Fan Yang, Jun Wang · 2019 · Expert Review of Molecular Diagnostics
ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy
Samla Gauri, Mohd Ridzuan Ahmad · 2020 · Journal of Sensors
Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion
Sarah Østrup Jensen, Nadia Øgaard, Hans Jørgen Nielsen, Jesper B. Bramsen, Claus L. Andersen · 2020 · Clinical Chemistry
The roles of small extracellular vesicles in lung cancer: Molecular pathology, mechanisms, diagnostics, and therapeutics
Yi Liu, Yiqiu Xia, Jillian Smollar, Wenjun Mao, Yuan Wan · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic
Alessia Cimadamore, Liang Cheng C, Francesco Massari, Matteo Santoni, Laura Pepi, Carmine Franzese, Marina Scarpelli, Antonio Lopez-beltran B, Andrea Benedetto Galosi, Rodolfo Montironi · 2021 · International Journal of Molecular Sciences
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
Alvida Qvick, Bianca Stenmark, Jessica Carlsson, Johan Isaksson, Christina Karlsson, Gisela Helenius · 2021 · Molecular Medicine
Translational Utility of Liquid Biopsies in Thyroid Cancer Management
Ayanthi A. Wijewardene, Marthe Chehade, Matti L. Gild, Roderick John Clifton-Bligh, Martyn Bullock · 2021 · Cancers
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastián Mondaca, Emily S. Lebow, Azadeh Namakydoust, Pedram Razavi, Jorge Sergio Reis-Filho, Ronglai Shen, Michael David Offin, Hai‐Yan Tu, Yonina R. Murciano‐Goroff, Chong‐Rui Xu et al. · 2021 · Lung Cancer
The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
Yuanyuan Lu, Li Li · 2021 · Technology in Cancer Research & Treatment
Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels
Lizhi Yu, Gonzalo Lopez, John Rassa, Yixin Wang, Tara Basavanhally, Andrew J. Browne, Chang-Pin Huang, Lauren Dorsey, Jin Jen, Sarah Hersey · 2022 · PLoS ONE
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
Lei Chen, Anna Eriksson, Simone Weström, Tatjana Pandzic, Sören Lehmann, Lucia B. Cavelier, Ulf D. Landegren · 2022 · Nature Communications